Player FM 앱으로 오프라인으로 전환하세요!
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Manage episode 299854748 series 2738732
Episode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression.
In this episode, we discuss:
- Lars’ experience overcoming Treatment-Resistant Depression with psilocybin
- The nuances of clinical trials and psilocybin dosing protocols
- Compass Pathways’ Intellectual Property strategy
- What additional indications and therapies Compass Pathways is interested in
Links to topics discussed in this episode:
Compass Pathways, Lars Wilde
COMP360
SSRI, SNRI
Christian Angermayer, Robin Carhart-Harris, Michael Pollan
Vivaneo
Quercis Pharma
TRD (Therapy-Resistant Depression)
Compass Phase 2B Trial
Jazz Pharmaceuticals
Compass Pathways 2 US patents
Oregon Psilocybin Therapy Measure 109
Read the transcript here.
Watch episode 10 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Hosts: Matias Serebrinsky and Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh
Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional music: River Meditation by Jason Shaw and Thea by Muted Circus
48 에피소드
Manage episode 299854748 series 2738732
Episode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression.
In this episode, we discuss:
- Lars’ experience overcoming Treatment-Resistant Depression with psilocybin
- The nuances of clinical trials and psilocybin dosing protocols
- Compass Pathways’ Intellectual Property strategy
- What additional indications and therapies Compass Pathways is interested in
Links to topics discussed in this episode:
Compass Pathways, Lars Wilde
COMP360
SSRI, SNRI
Christian Angermayer, Robin Carhart-Harris, Michael Pollan
Vivaneo
Quercis Pharma
TRD (Therapy-Resistant Depression)
Compass Phase 2B Trial
Jazz Pharmaceuticals
Compass Pathways 2 US patents
Oregon Psilocybin Therapy Measure 109
Read the transcript here.
Watch episode 10 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Hosts: Matias Serebrinsky and Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh
Find us at businesstrip.fm
Follow us on Instagram and Twitter!
Theme music by Dorian Love
Additional music: River Meditation by Jason Shaw and Thea by Muted Circus
48 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.